To our knowledge, this is the first study to demonstrate that defective interaction between CaM and RyR2 is essential to activate hypertrophic signaling owing to pressure-overload and that genetic enhancement of CaM binding to RyR2 protects against cardiac hypertrophy. The gene discussed is CALM1; the disease is cardiac hypertrophy.